In many cancers, the general methylation pattern of the DNA is changed, and the promoter region of Keap1 becomes hypermethylated, resulting in the decreased transcription of the Keap1 protein and the release of Nrf2 [31,35,36,37]. The gene discussed is KEAP1; the disease is cancer.